SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001005286-23-000027
Filing Date
2023-01-11
Accepted
2023-01-11 16:58:14
Documents
14
Period of Report
2023-01-11
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lndc-20230111.htm   iXBRL 8-K 43953
2 EX-99.1 lifecorebiomedicalreceiv.htm EX-99.1 5288
6 lifecorebiomedicalreceiv001.jpg GRAPHIC 236593
  Complete submission text file 0001005286-23-000027.txt   516915

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lndc-20230111.xsd EX-101.SCH 1981
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lndc-20230111_lab.xml EX-101.LAB 24137
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lndc-20230111_pre.xml EX-101.PRE 12589
8 EXTRACTED XBRL INSTANCE DOCUMENT lndc-20230111_htm.xml XML 11066
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

IRS No.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0528
Type: 8-K | Act: 34 | File No.: 000-27446 | Film No.: 23524129
SIC: 2834 Pharmaceutical Preparations